OTC Watch

All stocks / CUBT

Curative Biotechnology Inc CUBT

Curative Biotechnology (CUBT): no warning signs from our rules in the last 12 months. Each fact links to its SEC filing.

OTCIDFlorida, USA
Live quote on OTC Markets

Market listing

Full name
CURATIVE BIOTECHNOLOGY INC
Market tier
OTC Pink Current
Trading status
Active
Last trade
Nov 16
Source: Stockwatch, 2026-11-17

News headlines

Curative Biotechnology, Inc. Issues Letter to Shareholders
2026-09-11 07:00 · News Release
Curative Biotechnology Announces U.S. Patent Allowance Strengthening Core Ophthalmology Platform
2026-07-16 07:00 · News Release
Curative Biotechnology Advances Translational Ophthalmology Program Through PennVet Research Agreement
2026-05-07 07:00 · News Release
Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply of Metformin Topical Ophthalmic Therapy
2026-04-15 08:08 · News Release
Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting
2026-03-23 19:05 · News Release
Curative Biotechnology Announces Canadian Patent Allowance
2026-01-23 08:45 · News Release
Curative Biotechnology, Inc. Announces Letter to Shareholders
2025-11-18 08:15 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

Signals

No warning signs found in the last 12 months of SEC records. That is not a clean bill of health; it only means none of our rules fired.

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2025-12-22 RWRW

Common questions about CUBT

Does CUBT file reports with the SEC?

Yes. Curative Biotechnology files with the SEC under company number 0001400271. The most recent filing we hold is a RW dated 2025-12-22.

Source record

Has CUBT filed reports late?

We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.